Historical review of interstitial prostate brachytherapy

Iranian Journal of Radiation Research

Volumn 5, Issue 4, 2008, Pages 153-168

  Awan, S B ^a,b   Hussain, M ^b   Dini, S A ^a   Meigooni, A S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Advancements; AU 198; Cs 131; I 125; Interstitial brachytherapy; Pd 103; RA 226

Indexed keywords

CESIUM 131; GOLD 198; IODINE 125; PALLADIUM 103; RADIUM 226;

ANISOTROPY; DOSE CALCULATION; DOSIMETRY; DRUG HALF LIFE; DRUG IMPLANTATION; GASTROINTESTINAL IRRITATION; GEOMETRY; HUMAN; INCONTINENCE; NONHUMAN; PAIN; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION MEASUREMENT; RADIOISOTOPE THERAPY; REVIEW; TREATMENT PLANNING; URINARY URGENCY;

EID: 77952497447     PISSN: 23223243     EISSN: 17284562     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W (2000) The role of external beamradiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol, 57: 273-278.
2. Bratt O (2007) The urologist's guide to low dose-rate interstitial brachytherapy with permanent seed implants for localized prostate cancer. BJU Int, 99: 497-501.
3. Kaye KW (1991) Transrectal ultrasonography of BPH. Contemp Urol, 3: 34-36; 41-50.
4. Prestidge BR (1998) Radioisotopic implantation for carcinoma of the prostate: does it work better than it used to? Semin Radiat Oncol, 8: 124-131.
5. Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC (2006) Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis". Cancer, 107: 2392-2400.
6. Aronowitz JN (2002) Benjamin Barringer: originator of the transperineal prostate implant. Urology, 60: 731-734.
7. Aronowitz JN (2002) Dawn of prostate brachytherapy: 1915-1930. Int J Radiat Oncol Biol Phys, 54: 712-718.
8. Ding M, Gardi L, Wei Z, Fenster A (2005) 3D TRUS Image segmentation in prostate brachytherapy. Conf Proc IEEE Eng Med Biol Soc, 7: 7170-7173.
9. Guedea F, Aguilo F, Polo A, Langley S, Laing R, Henderson A, Aaltomaa S, Kataja V, Palmgren J, Bladou F, Salem N, Gravis G, Losa A, Guazzoni G, Nava L (2006) Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer. Radiother Oncol, 80: 57-61.
10. Carey B and Swift S (2007) The current role of imaging for prostate brachytherapy. Cancer Imaging, 7: 27-33.
11. Ling CC, Li WX, Anderson LL (1995) The relative biological effectiveness of I-125 and Pd-103. Int J Radiat Oncol Biol Phys, 32: 373-378.
12. Nag S, Scaperoth DD, Badalament R, Hall SA, Burgers J (1995) Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. Urology, 45: 87-92.
13. Nag S, Cole PE, Crocker I, Jani SK, Kishnasastry KV, Massullo V, Nath R, Nori D, Parikh S, Rubin P, Speiser B, Teirstein PS, Tripuraneni P, Waksman R, Williamson JF (1999) The American brachytherapy society perspective on intravascular brachytherapy. Cardiovasc Radiat Med, 1: 8-19.
14. Pasteau O and Degrais P (1914) The Radium treatment of cancer of the prostate. Arch Roentgen Ray, 18: 396-410.
15. Rivard MJ, Butler WM, Devlin PM, Hayes JK Jr., Hearn RA, Lief EP, Meigooni AS, Merrick GS, Williamson JF (2007) American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy, 6: 34-37.
16. Holm HH (1997) The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol, 13: 431-437.
17. Forssell G (1931) "La lutte sociale contre le cancer". J de Radiol et d'Electrol, 15: 621-34.
18. Quimby EH (1952) Radiation dosage planning and dosage calculation. Radiology, 58: 881-882.
19. Quimby EH, Castro V, Soifer C (1954) Dosage determination for rotation therapy in the horizontal plane. Radiology, 63: 201-219.
20. Quimby EH (1956) The background of radium therapy in the United States, 1906-1956. Am J Roentgenol Radium Ther Nucl Med, 75: 443-450.
21. Quimby EH and Braestrup CB (1950) Planning the radioisotope program in the hospital. Am J Roentgenol Radium Ther Nucl Med, 63: 6-12.
22. Paterson R and Parker H (1995) A dosage system for gamma ray therapy. Br J Radiol, 68: 808.
23. Simon N (1965) Iridium 192 as a radium Substitute. Am J Roentgenol Radium Ther Nucl Med, 93: 170-178.
24. Flocks RH (1960) Newer developments in the management of early prostatic cancer. Postgrad Med, 28: 46-50.
25. Bennett JE (1968) Treatment of carcinoma of the prostate by cobalt-beam therapy". Radiology, 90: 532-535.
26. Lawrence D, Sondhaus C, Feder B and Scallon J (1966) Soft X-ray "seeds" for cancer therapy. Radiology, 86: 143.
27. Henschke UK and Lawrence DC (1965) Cesium-131 seeds for permanent implants. Radiology, 85: 1117-1119.
28. Whitmore WF Jr., Hilaris B, Grabstald H (1972) Retropubic implantation to iodine-125 in the treatment of prostatic cancer. J Urol, 108: 918-920.
29. Whitmore WF Jr., Hilaris B, Grabstald H (1972) Retropubic implantation of iodine 125 in the treatment of prostatic cancer. Trans Am Assoc Genitourin Surg, 64(55-57).
30. Hilaris BS, Whitmore WF Jr., Batata MA, Grabstald H (1974) Radiation therapy and pelvic node dissection in the management of cancer of the prostate. Am J Roentgenol Radium Ther Nucl Med, 121: 832-838.
31. Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, Hilaris BS, Whitmore WF (1991) "The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys, 21: 537-547.
32. Hilaris BS, Whitmore WF, Batata M, Barzell W (1977) Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection. Int J Radiat Oncol Biol Phys, 2: 631-637.
33. Sylvester JE, Blasko JC, Grimm PD, Meier R, Malmgren JA (2003) Ten- year biochemical relapse- free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Int J Radiat Oncol Biol Phys, 57: 944-952.
34. Grimm PD, Blasko JC, Sylvester JE, Heaney C, Gasparich J, Quackenbush J, Gottesman J, Downey J, Grier D, Roddy T, Nellans R, Sood N, Wahl D (2004) Technical improvement in permanent seed implantation: a two- stage brachytherapy system. Description and comparison with current technique. Brachytherapy, 3: 34-40.
35. Grimm P, Sylvester J, Blasko J (2003) See migration strands vs loose seeds. Presented at: Sixth Annual Advanced Prostate Brachytherapy Conference; November 10-11, Seattle, WA.
36. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I (1983) Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultra-sonography. J Urol, 130: 283-286.
37. Henschke UK and Cevc P (1968) Dimension averaging a simple method for dosimetry of interstitial implants. Radiobiol Radiother (Berl), 9: 287-298.
38. Blasko JC, Ragde H, Grimm PD (1991) Transperineal ultrasound- guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl, 13: 113-118).
39. Morton JD and Peschel RE (1988) Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer. Int J Radiat Oncol Biol Phys, 14: 1153-1157.
40. Morton JD, Harrison LB, Peschel RE (1986) Prostatic cancer therapy: comparison of external beam radiation and I-125 seed implantation treatment of stages B and C neoplasms". Radiology, 159: 249-252.
41. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK (1998) A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys, 41: 101-108.
42. Willins J and Wallner K (1997) CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys, 39: 347-353.
43. Nag S, Beyer D, Friedland J, Grimm P, Nath R (1999) American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys, 44: 789-799.
44. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) The American brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys, 46: 221-230.
45. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys, 22: 209-234.
46. Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, Mitch MG, Nath R, Williamson JF (2004) Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys, 31: 633-674.
47. Deming CL (1922) Results in one hundred cases of cancer of prostate and seminal vesicle treated with radium. Surg Gynecol Obstet, 34: 99-118.
48. Flocks RH and Culp DA (1960) Radiation therapy of early prostatic cancer." Springfield, IL: Charles C. Thomas.
49. Ragde H, Grado GL, Nadir B, Elgamal AA (2000) Modern prostate brachytherapy. CA Cancer J Clin, 50: 380-393.
50. Ragde H and Korb L (2000) Brachytherapy for clinically localized prostate cancer. Semin Surg Oncol, 18: 45-51.
51. Murphy MK, Piper RK, Greenwood LR, Mitch MG, Lamperti PJ, Seltzer SM, Bales MJ, Phillips MH (2004) Evaluation of the new cesium-131 seed for use in low- energy X-ray brachytherapy. Med Phys, 31: 1529-1538.
52. Wallace RE and Fan JJ (1999) Dosimetric characterization of a new design 103-palladium brachytherapy source. Med Phys, 26: 2465-2470.
53. Wallace RE and Fan JJ (1999) Report on the dosimetry of a new design 125Iodine brachytherapy source. Med Phys, 26: 1925-1931.
54. Meigooni AS, Hayes JL, Zhang H, Sowards K (2002) Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source. Med Phys, 29: 2152-2158.
55. Meigooni AS, Dini SA, Sowards K, Hayes JL, Al-Otoom A (2002) Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source. Med Phys, 29: 939-942.
56. Monroe JI and Williamson JF (2002) Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed. Med Phys, 29: 609-621.
57. Barringer BS (1917) Radium in the treatment of carcinoma of the bladder and prostate. JAMA, 68: 1227-1230.
58. Machtens S, Baumann R, Hagemann J, Warszawski A, Meyer A, Karstens JH, Jonas U (2006) Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol, 24: 289-295.
59. Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB (2002) A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys, 53: 490-496.
60. White AT, Wilson TE, Davis SL, Petajan JH (2000) Effect of pre-cooling on physical performance in multiple sclerosis. Mult Scler, 6: 176-180.
61. Older RA, Synder B, Krupski TL, Glembocki DJ, Gillenwater JY (2001) Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol, 165: 1590-1592.
62. Steinfeld AD, Donahue BR, Plaine L (1991) Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology, 37: 149-150.
63. Tapen EM, Blasko JC, Grimm PD, Ragde H, Luse R, Clifford S, Sylvester J, Griffin TW (1998) Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys, 42: 1063-1067.
64. Dawson JE, Wu T, Roy T, Gu JY, Kim H (1994) Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants. Radiother Oncol, 32: 268-270.
65. Roberson PL, Narayana V, McShan DL, Winfield RJ, McLaughlin PW (1997) Source placement error for permanent implant of the prostate. Med Phys, 24: 251-257.
66. Di Muzio N, Longobardi B, Losa A, Mangili P, Nava LD, Rigatti P, Calandrino R, Villa E, Guazzoni G (2003) Seed migration in prostate brachytherapy: a reimplant case report. Br J Radiol, 76: 913-915.
67. Davis BJ, Pfeifer EA, Wilson TM, King BF, Eshleman JS, Pisansky TM (2000) Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol, 164: 1661.
68. Al-Qaisieh B, Carey B, Ash D, Bottomley D (2004) The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer. Int J Radiat Oncol Biol Phys, 59: 397-399.
69. Fuller DB, Koziol JA, Feng AC (2004) Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy, 3: 10-19.
70. Lee WR, deGuzman AF, Tomlinson SK, McCullough DL (2002) "Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy. Radiother Oncol, 65: 123-127.
71. Fagundes U (2003) Dosimetric analysis comparing free seeds vs. a novel technique using Rapid Strand prostate brachytherapy. Presented at: Sixth Annual Advanced Prostate Brachytherapy Conference; November 10-11, Seattle, WA, USA.
72. Awan SB, Meigooni AS, Mokhberiosgouei R, Hussain M (2006) Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources. Med Phys, 33: 4271-4279.
73. Lin K, Lee SP, Cho JS, Reiter RE, DeMarco JJ, Solberg TD (2007) Improvements in prostate brachytherapy dosimetry due to seed stranding. Brachytherapy, 6: 44-48.
74. Meigooni AS, Zhang H, Clark JR, Rachabatthula V, Koona RA (2004) Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants. Med Phys, 31: 3095-3105.
75. Dini SA, Awan SB, Dou K, Meigooni AS (2007) TG-43U1 parameterization of elongated RadioCoil 103Pd brachytherapy sources. J Appl Clin Med Phys, 8: 2435.
76. Christen T (1914) Radiometry. Arch Roentgenol Ray, 29: 210.
77. Loftus TP (1970) Standardization of cesium-137 gammaray sources in terms of exposure units (roentgens). J Res Natl Bur Stand, 74: 1-6.
78. Loftus T P (1980) Standardization of iridium-192 gamma-ray sources in terms of exposure. J Res Natl Bur Stand, 85: 19-25.
79. Hilaris BS (1976) Interstitial radiation with iodine-125. Panminerva Med, 18: 28-31.
80. Hilaris BS, Kim JH, Tokita N (1976) Low energy radionuclides for permanent interstitial implantation. AJR Am J Roentgenol, 126: 171-178.
81. Krishnaswamy V (1978) Dose distribution around an 125I seed source in tissue. Radiology, 126: 489-491.
82. Chiu-Tsao ST and Anderson LL (1991) Thermoluminescent dosimetry for 103Pd seeds (model 200) in solid water phantom. Med Phys, 18: 449-452.